Current Cancer Drug Targets

Editor-in-Chief

Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
(USA)

Personal Subscription
Become EABM
Become Reviewer
Call for Editor
Volume: 5 Issue: 5, August

Antiproliferative Efficacy of Angiotensin II Receptor Blockers in Prostate Cancer

Volume:5   Issue: 5
Pp: 307-323
Hiroji Uemura, Noboru Nakaigawa, Hitoshi Ishiguro and Yoshinobu Kubota
DOI: 10.2174/1568009054629663
Published on: 01 March, 2012

Inflammation and Cancer: When NF-κB Amalgamates the Perilous Partnership

Volume:5   Issue: 5
Pp: 325-344
Marina A. Dobrovolskaia and Serguei V. Kozlov
DOI: 10.2174/1568009054629645
Published on: 01 March, 2012

Molecular Targets from VHL Studies into the Oxygen-Sensing Pathway

Volume:5   Issue: 5
Pp: 345-356
M. A. Maynard and M. Ohh
DOI: 10.2174/1568009054629672
Published on: 01 March, 2012

The Therapeutic Potential of 4-1BB (CD137) in Cancer

Volume:5   Issue: 5
Pp: 357-363
Kyung-Ok Nam, Woo J. Kang, Byoung S. Kwon, Sung J. Kim and Hyeon-Woo Lee
DOI: 10.2174/1568009054629681
Published on: 01 March, 2012

The MCM Complex: Its Role in DNA Replication and Implications for Cancer Therapy

Volume:5   Issue: 5
Pp: 365-380
Ming Lei
DOI: 10.2174/1568009054629654
Published on: 01 March, 2012